“eli-lilly” Archives

in
Entry Author Date Location
Teva Seeks to Keep Pace in Migraine Drug Race With Trial Results 05/31/17 New York
Eli Lilly Migraine Drug Hits Study Goals, Paves Way for FDA Filing 05/12/17 Indiana
Merck Immunotherapy Drug Notches Another FDA Win in Lung Cancer 05/11/17 New York
Bio Roundup: NIH Precision Boost, AHCA to Senate, New Drugs & More 05/05/17 National
Zymeworks Bags $58M in IPO to Bankroll Cancer Drug Trials 04/28/17 Seattle
Radius Nabs FDA OK For New Bone Drug With Rival Amgen Close Behind 04/28/17 Boston
Gates Foundation Leads $45.5M Round for Gerngross’s Biotech Arsanis 04/26/17 Boston
Bio Roundup: Spinraza Woes, Science March, Baseline Launch & More 04/21/17 National
Phoenix Shops Its Cancer Drug as Potential Alzheimer’s Treatment 04/20/17 Texas
Cancer Drugmaker G1 Therapeutics Makes IPO Pitch To Wall Street 04/17/17 Raleigh Durham
FDA Nixes Lilly, Incyte RA Drug, Seeks More Dosing and Safety Data 04/14/17 Indiana
IBRI, Dow Agrosciences, Lilly Partner on Molecular Safety Database  03/28/17 Indiana
Eli Lilly Reveals $850M Capital Spending Plan for Indiana and Beyond 03/24/17 Indiana
Bio Roundup: Trumpcare Wavers, Amgen Courts Payers, Critics Circle PTC 03/24/17 National
BioCrossroads Report: Steady Growth for Life Sciences in Indiana 02/24/17 Indiana
Xenex Gets $38M From Essex Woodlands, Others for Germ-Zapping Robots 02/24/17 Texas
Merck Alzheimer Drug Is Latest To Fail In A Big Study 02/15/17 National
Bio Roundup: Travel Ban Block, Gilead Shock, Dean Kamen Talk & More 02/10/17 National
Bayer Enlists Trana Discovery to Find New Fungicides for Field Crops 02/08/17 Raleigh Durham
With Another Migraine Drug Bet, Lilly Snaps Up CoLucid For $960M 01/18/17 Indiana
Anthera’s Shares Tumble After Cystic Fibrosis Drug Fails in Phase 3 12/28/16 San Francisco
14 for ’17: Key Clinical Data To Watch For Next Year (Part 2) 12/22/16 National
NY Bio Surge Continues as De Blasio Unveils $500M, 10-Year Life Sci Plan 12/13/16 New York
ApoGen Biotech Lands $7M to Take On Drug Resistance in Cancer 12/12/16 Seattle
Amyloid Hypothesis Lives On—Solanezumab, Too, Despite “Siren Song” 12/09/16 Indiana
Eli Lilly Diabetes Drug Gets FDA OK for Reducing Heart Health Risks 12/02/16 Indiana
Bio Roundup: CAR-T Ups & Downs, Lilly’s Failure, Myeloma & More 12/02/16 National
Coming in 2017: The Union, Downtown Indy’s Massive New Tech Space 11/30/16 Indiana
Tetra Discovery Raises $10M Series A, Advances Alzheimer’s Drug 11/30/16 Detroit Ann Arbor
Amyloid Hypothesis Takes a Hit As Lilly’s Alzheimer’s Drug Fails Again 11/23/16 Indiana
Page 2 of 15 « previous page · next page »